BY Health & Biotech Special Report

EZZ is capitalising on growing tennis fan base in China with Australian Open sponsorship. Pic: Getty Images

 

• EZZ is raising brand awareness in China and Southeast Asia as key regional sponsor for Australian Open
• Company is the wellness and supplements sponsor in the region for second year of three-year deal
• Company appoints new directors to further its growth strategy in 2026, including in new US market

Special Report: To stay at the top of its game and keep brand awareness front of mind, EZZ Life Science is looking to rally excitement around the Australian Open for millions of tennis fans across China and Southeast Asia in the second year of its regional sponsorship deal.

Under the three-year deal with the Australian Open, which began in 2025 and marked its biggest marketing venture to date, the company is focused on raising brand awareness with an extensive Chinese and Southeast Asian viewer base.

China is experiencing something of a ‘golden era’ for tennis, driven by the rise of Olympic women’s singles champion and Grand Slam singles finalist Zheng Qinwen, Grand Slam women’s doubles champion Wang Xinyu and breakthrough performances from male stars including Zhang Zhizhen.

Showpiece tournaments such as the China Open and Shanghai Masters are drawing world-class fields, record crowds and growing global attention.

It is estimated there are around 25 million people now actively playing tennis in the Middle Kingdom, with 55,000 tennis courts and more being built as part of infrastructure growth.

EZZ Life Science (ASX:EZZ) chief strategy officer and former chairman Glenn Cross said that because Australia was in a similar time zone to China, more than 300 million tennis fans were expected to watch the Australian Open across the two-week tournament.

“We are the wellness and supplements sponsor, so we get significant advertising in China and Southeast Asia,” Cross said.

“Our logo will be digitally enhanced on the side of the court for viewers in the region, so for us it is all about brand awareness.”

Furthermore, EZZ uses the sponsorship to bring key Chinese and Southeast Asian influencers and distributors to the Australian Open.

 

China and Southeast Asia firmly in play
EZZ has been enjoying success in key Asian markets, particularly China, with its reputation for high-quality health and wellness innovation.

The company formulates, produces, markets and distributes health supplements under the EZZ brand in Asia, investing in R&D with third parties to develop products for which it can develop a strong market position.

Cross said more than 65% of EZZ’s revenue now came from China with the company having a high presence and strong digital marketing strategies on leading Chinese e-commerce platforms including Douyin, Kuaishou and Tmall.

“I talk to people from the Australian China Business Council or at other events and they know of EZZ,” Cross said.

“We have become a significant brand in the health and wellness sector on leading e-commerce platforms in China with three or four of our products in the top sellers.”

 

New board members to support EZZ’s growth
Meanwhile, two directors have been appointed to the EZZ board to strengthen governance as the company continues to execute its growth strategy, including in its other main target market, the US.

Christine Chen, who has been with the company since its establishment, has been appointed as an executive director, and will continue her current executive responsibilities, bringing extensive experience in finance, taxation and operational management.

Chen has played a key role in supporting EZZ’s growth, compliance, and governance frameworks, with the appointment formalising her long-standing contribution and ensuring continuity at the executive level.

Meanwhile, with experience in administration, stakeholder engagement and community services, Janice Hsu has been appointed as a non-executive director.

Hsu’s background provides a people-focused and governance-oriented perspective, supporting the board as the company scales its operations and organisational structure.

“Christine’s deep knowledge of EZZ and her strong financial and governance expertise provide continuity at the executive level,” said CEO and interim chair Mark Qin.

“Janice adds valuable governance perspective and stakeholder insight, supporting the Board as we continue to execute EZZ’s growth strategy.”

Subsequent to the board changes, EZZ has also appointed Gary Liu as non-executive chair, effective immediately.

Liu brings extensive international experience across listed company leadership, capital markets and strategic development, with a strong focus on Asia-Pacific markets.

CEO Mark Qin will continue in his executive role, having served as interim chair during the board appointment process.

 

Ready to ace the US market
EZZ officially entered the US market last year with the launch of a dedicated brand EZZDAY and an initial range of four health supplements registered with the US Food and Drug Administration (FDA).

The initial US range is targeted at four high-growth supplement areas including digestive health, women’s wellness, detox and anti-ageing.

To support the market launch, EZZ started US-based manufacturing to meet local quality standards, consumer expectations and ensure supply chain resilience.

The company has a wholly owned US subsidiary EZZ Life Science Holdings USA Inc, which is being used as the trading entity for the substantial health and wellness market.

“We’ve now just got to develop the business in the US and have had our products approved by the FDA and established our new US-focused brand EZZDAY,” Cross said.

“It’s now just about increasing our presence on the e-commerce channels in the US including Shopify, Amazon and TikTok.

“We also want to further the distribution into pharmacy, retail and specialty wellness stores in the US.”

This article was developed in collaboration with EZZ life Science, a Stockhead advertiser at the time of publishing.

This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.